Decera Clinical Education Medical Specialties Podcast Podcast Por Clinical Care Options arte de portada

Decera Clinical Education Medical Specialties Podcast

Decera Clinical Education Medical Specialties Podcast

De: Clinical Care Options
Escúchala gratis

Obtén 3 meses por US$0.99 al mes

Weekly updates on new data, current advances, and best practices in patient care for a variety of medical specialties including NASH, diabetes, muscular dystrophy, and more from Clinical Care Options. Gain practical strategies and earn CME/CE credit for selected episodes.2019-2020 CCO Podcast: Medical Specialties Educación Higiene y Vida Saludable
Episodios
  • Bringing Obesity Advances to Primary Care: 2025 in Review and a Look Ahead
    Dec 15 2025

    Listen in as Jay H. Shubrook, DO, FACOFP, FAAFP, and Chrisopher Weber, MD, FAAP, FACP, CSCS, daBOM, FOMA, discuss the latest advances in caring for patients with overweight or obesity in the primary care setting, including:

    • The Lancet Commission’s new obesity definitions and diagnostic criteria
    • Key data on incretin-based antiobesity medications like semaglutide and tirzepatide
    • Best practices for patient discussions
    • Strategies for incorporating new evidence in your primary care practice

    Presenters
    Jay H. Shubrook, DO, FACOFP, FAAFP
    Professor and Diabetologist
    Department of Clinical Sciences and Community Health
    Touro University California College of Osteopathic Medicine
    Vallejo, California

    Christopher Weber, MD, FAAP, FACP, CSCS, daBOM, FOMA
    Bariatric Services Medical Director, Ascension Wisconsin
    Obesity Medicine Director, Ascension Columbia St Mary’s Bariatric Center
    Trustee, Obesity Medicine Association
    Adjunct Assistant Professor of Pediatrics
    Medical College of Wisconsin
    Milwaukee, Wisconsin

    Link to full program:
    https://bit.ly/4rG7QQp


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Más Menos
    26 m
  • Setting Our Sights on Symptom Management: Raising the Bar in PBC Management Podcast
    Dec 11 2025

    Historically, key symptoms of primary biliary cholangitis (PBC), such as pruritus and fatigue, have been understudied and undertreated. Listen now to learn how symptom management should be considered independently of PBC management, and how new therapeutic agents can help.

    Topics covered include:

    • Mechanisms of pruritus and fatigue in PBC
    • Nonpharmacologic treatment options
    • An overview of clinical trial data supporting second-line agents for symptom management:
    • Bezafibrate
    • Elafibranor
    • Seladelpar
    • Investigational agents:
    • Volixibat
    • Linerixibat
    • Setanaxib

    This episode is the third of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode:
    https://bit.ly/44ZJ5os

    Presenters:
    Christopher L. Bowlus, MD
    Lena Valente Professor and Chief
    Division of Gastroenterology and Hepatology
    School of Medicine
    University of California Davis
    Sacramento, California

    Aparna Goel, MD
    Clinical Associate Professor of Medicine
    Division of Gastroenterology and Hepatology
    Stanford University
    Palo Alto, California

    Aliya F. Gulamhusein, MD,
    MPH, FRCPC
    Professorship in PSC Research
    Clinician Investigator, Toronto General Hospital
    Assistant Professor, University of Toronto
    Division of Gastroenterology and Hepatology
    University Health Network
    Toronto, Canada

    Get access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify.


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Más Menos
    38 m
  • Second-line Agents for Achieving Treatment Goals: Raising the Bar in PBC Management Podcast
    Dec 11 2025

    New therapeutic agents for second-line treatment are raising the bar for primary biliary cholangitis (PBC) management. Listen now to learn how to incorporate these new agents into clinical practice and how these agents will impact attainment of treatment goals.

    Topics covered include:

    • Available agents for second-line treatment of PBC
    • An overview of clinical trial data supporting second-line agents:
    • Obeticholic acid (OCA)
    • Bezafibrate
    • Elafibranor
    • Seladelpar

    This episode is the second of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode: https://bit.ly/48MEc3r

    Presenters:

    Christopher L. Bowlus, MD
    Lena Valente Professor and Chief
    Division of Gastroenterology and Hepatology
    School of Medicine
    University of California Davis
    Sacramento, California

    Aparna Goel, MD
    Clinical Associate Professor of Medicine
    Division of Gastroenterology and Hepatology
    Stanford University
    Palo Alto, California

    Aliya F. Gulamhusein, MD, MPH, FRCPC
    Professorship in PSC Research
    Clinician Investigator, Toronto General Hospital
    Assistant Professor, University of Toronto
    Division of Gastroenterology and Hepatology
    University Health Network
    Toronto, Canada

    Get access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify.


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Más Menos
    17 m
Todavía no hay opiniones